TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
254
|
43
|
5 |
| Financial expenses |
126
|
170
|
66 |
| Earnings before taxes |
-1,901
|
-2,044
|
-1,735 |
| EBITDA |
-1,582
|
-1,614
|
-1,394 |
| Total assets |
1,340
|
1,950
|
2,524 |
| Current assets |
649
|
1,062
|
1,314 |
| Current liabilities |
346
|
693
|
185 |
| Equity capital |
994
|
1,257
|
2,339 |
| - share capital |
808
|
540
|
471 |
| Employees (average) |
6
|
6
|
7 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
74.2%
|
64.5%
|
92.7% |
| Turnover per employee |
42
|
7
|
1 |
| Profit as a percentage of turnover |
-748.4%
|
-4753.5%
|
-34700% |
| Return on assets (ROA) |
-132.5%
|
-96.1%
|
-66.1% |
| Current ratio |
187.6%
|
153.2%
|
710.3% |
| Return on equity (ROE) |
-191.2%
|
-162.6%
|
-74.2% |
| Change turnover |
212
|
38
|
-8 |
| Change turnover % |
497%
|
865%
|
-63% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-14%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.